Drug Quality and Registration (DruQuaR) Group, Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 , 9000 Ghent, Belgium.
Drug Quality and Registration (DruQuaR) Group, Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460 , 9000 Ghent, Belgium.
J Pharm Biomed Anal. 2018 Jan 5;147:50-64. doi: 10.1016/j.jpba.2017.08.031. Epub 2017 Aug 24.
Circular dichroism (CD) is a non-destructive and powerful technique for providing structure and ligand interaction information of small molecules as well as biotechnological medicines. While CD is a well-established technique in biomedical research, and different types and variants of CD do exist, the focus of this review is on the pharmaceutical quality control (QC) aspects of the classic electronic CD (ECD). The basic principles of the CD technique are initially described, followed by a systematic literature research on pharmaceutical aspects encompassing chiral small molecules, bio-polymers (i.e. proteins, peptides and nucleic acids), medicine-biotarget interaction (i.e. small molecule-albumin interaction, protein-receptor interaction and peptide-biotarget interaction) and medicine changes (i.e. chemical modification, biosimilar/bio-better with stability and aggregation). In addition, unstructured literature was also included covering the use of CD mainly in discovery and fundamental research, but which might shift towards the pharmaceutical QC field as well in the future.
圆二色性(CD)是一种非破坏性且强大的技术,可提供小分子以及生物技术药物的结构和配体相互作用信息。虽然 CD 在生物医学研究中已经是一种成熟的技术,并且确实存在不同类型和变体的 CD,但本篇综述的重点是经典电子圆二色性(ECD)的药物质量控制(QC)方面。本文首先描述了 CD 技术的基本原理,然后对涵盖手性小分子、生物聚合物(即蛋白质、肽和核酸)、药物-生物靶相互作用(即小分子-白蛋白相互作用、蛋白质-受体相互作用和肽-生物靶相互作用)和药物变化(即化学修饰、稳定性和聚集的类似物/更好的生物制品)的药物方面进行了系统的文献研究。此外,还包括了非结构化的文献,这些文献主要涵盖 CD 在发现和基础研究中的应用,但将来也可能转向药物 QC 领域。